Header Logo

Connection

Nancy Reau to Humans

Back to Details
This is a "connection" page, showing publications Nancy Reau has written about Humans.
Nancy Reau
Connection Strength
0.624
Humans
  1. Patients With Autoimmune Hepatitis and Nonalcoholic Fatty Liver Disease: Characteristics, Treatment, and Outcomes. J Clin Gastroenterol. 2024 Jan 01; 58(1):91-97.
    View in: PubMed
    Score: 0.050
  2. What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages? Clin Liver Dis. 2023 11; 27(4):973-984.
    View in: PubMed
    Score: 0.048
  3. Use of tecovirimat for mpox infection followed by JYNNEOS vaccination postinfection in a liver transplant recipient. Transpl Infect Dis. 2023 Jun; 25(3):e14030.
    View in: PubMed
    Score: 0.047
  4. Liver Disease During Pregnancy. Am J Gastroenterol. 2022 10 01; 117(10S):44-52.
    View in: PubMed
    Score: 0.045
  5. The American Association for the Study of Liver Diseases: A history of the first 10 years and its presidents. Hepatology. 2022 09; 76(3):854-859.
    View in: PubMed
    Score: 0.044
  6. Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019. Adv Ther. 2021 12; 38(12):5777-5790.
    View in: PubMed
    Score: 0.043
  7. Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease. Am J Gastroenterol. 2021 10 01; 116(10):2089-2097.
    View in: PubMed
    Score: 0.042
  8. Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis?C. Adv Ther. 2021 01; 38(1):423-440.
    View in: PubMed
    Score: 0.040
  9. Liver Diseases During Pregnancy. Clin Liver Dis. 2019 05; 23(2):345-361.
    View in: PubMed
    Score: 0.035
  10. Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection. Hepatology. 2018 10; 68(4):1298-1307.
    View in: PubMed
    Score: 0.034
  11. Pregnancy after liver transplantation: Can renal function quell the fear? Liver Transpl. 2018 05; 24(5):583-584.
    View in: PubMed
    Score: 0.033
  12. HBV reactivation after HCV eradication: Deja Vu. Liver Int. 2017 07; 37(7):1088.
    View in: PubMed
    Score: 0.032
  13. Updates on hepatitis C virus therapy in the direct-acting antiviral era. Curr Opin Gastroenterol. 2017 May; 33(3):115-119.
    View in: PubMed
    Score: 0.031
  14. Generic medications for hepatitis C. Liver Int. 2016 07; 36(7):925-8.
    View in: PubMed
    Score: 0.029
  15. HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape. Liver Int. 2016 Apr; 36(4):488-502.
    View in: PubMed
    Score: 0.028
  16. Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis. Blood Adv. 2022 10 25; 6(20):5630-5633.
    View in: PubMed
    Score: 0.011
  17. Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS?CO13 HEPAVIH)". J Hepatol. 2020 03; 72(3):592-593.
    View in: PubMed
    Score: 0.009
  18. Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma. Dig Liver Dis. 2020 01; 52(1):98-101.
    View in: PubMed
    Score: 0.009
  19. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. N Engl J Med. 2015 Dec 31; 373(27):2608-17.
    View in: PubMed
    Score: 0.007
  20. Refined prediction of week 12 response and SVR based on week 4 response in HCV genotype 1 patients treated with peginterferon alfa-2a (40KD) and ribavirin. J Hepatol. 2012 Jun; 56(6):1276-82.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.